Skip to content

Improving Prospective Memory Via Telehealth

Improving Prospective Memory Via Telehealth: A Randomized Feasibility Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05129293
Acronym
TPMI
Enrollment
35
Registered
2021-11-22
Start date
2021-11-01
Completion date
2023-06-30
Last updated
2024-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

prospective memory, cognitive dysfunction, multiple sclerosis

Brief summary

Up to 70% of persons with multiple sclerosis (PwMS) experience cognitive impairment, which can have a significant impact on several aspects of their daily lives. One cognitive domain that has been shown to impact daily functioning, but is understudied in MS, is prospective memory (PM). While there have been successful PM interventions in other clinical populations, to date there has not been a specific PM intervention for PwMS that has been tested in a clinical trial. The study will be a double-masked randomized feasibility trial, with 18 participants randomized to a PM intervention and 18 participants randomized to an active control (psychoeducation). Participants will meet with an interventionist twice a week for four weeks. Feasibility will be assessed via 1) recruitment, enrollment, and retention; 2) adherence to the treatment; 3) treatment credibility and expectancy; and 4) treatment satisfaction. A preliminary effect size (Cohen's d) will be computed for the group difference using participants' performance on the Memory for Intentions Test, which will be given at baseline (week 1) and post-treatment (week 6). Participants will also complete a battery of neuropsychological measures as part of their baseline and post-treatment assessments.

Interventions

BEHAVIORALProspective Memory Intervention

Cognitive remediation focusing on prospective memory

BEHAVIORALEducational

Psychoeducation

Sponsors

Trinity Health Of New England
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of MS * Able to read, write, and speak in English * Between the ages of 18 and 60 * All genders * No history of other serious neurologic or psychiatric illness, including drug or alcohol misuse * No relapses within the past two months * Access to the Internet and a web camera * Not enrolled in a cognitive rehabilitation program within the past six months * Self-reported issues remembering places they have to be and things they have to do

Exclusion criteria

* No diagnosis of MS * Unable to complete the study protocol due to language barriers * Younger than 18 or older than 61 * No gender exclusions * History of other serious neurologic or psychiatric illness, including drug or alcohol misuse * Had a relapse within the past two months * No access to the Internet and/or a web camera * Currently enrolled or enrolled in a cognitive rehabilitation program within the past six months * No self-reported issues with remembering places they have to be or things they have to do

Design outcomes

Primary

MeasureTime frameDescription
Memory for Intentions Test Total Score PercentileSix weeksPerformance on objective prospective memory (overall performance). The MIST Total Score is calculated by summing the raw scores from the six subscales, which is transformed into percentiles using age- and education-stratified normative data. Scores ranged from \<1 9 (coded as 0 for analyses) to \>99 (coded as 100 for analyses), with higher scores indicating better prospective memory performance.
Memory for Intentions Test Time Cue Subscale PercentileSix weeksPerformance on objective prospective memory (time-based)

Secondary

MeasureTime frameDescription
Perceived Deficits Questionnaire-Prospective Memory SubscaleSix weeksSubjective prospective memory. The five items in the subscale are summed, with scores ranging between 0 and 20. Higher scores indicate more subjective prospective memory issues.

Countries

United States

Participant flow

Participants by arm

ArmCount
Prospective Memory Intervention
Participants randomized to the PM intervention (active group) will meet with an interventionist twice a week for four weeks. The first four sessions will focus on visual imagery, while the last four sessions will focus on implementation intentions. Participants will be led through a manualized treatment. Prospective Memory Intervention: Cognitive remediation focusing on prospective memory
17
Educational
The control group (Education) will meet with a research assistant for the same frequency of sessions and will receive psychoeducation on MS and cognitive functioning. The interventionists will be following a manual and accompanying PowerPoint slides. Educational: Psychoeducation
18
Total35

Baseline characteristics

CharacteristicEducationalTotalProspective Memory Intervention
Age, Continuous48.17 years
STANDARD_DEVIATION 9.8
47.74 years
STANDARD_DEVIATION 9.37
47.29 years
STANDARD_DEVIATION 9.15
Ethnicity (NIH/OMB)
Hispanic or Latino
4 Participants6 Participants2 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
14 Participants29 Participants15 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
Race
Black
1 Participants4 Participants3 Participants
Race/Ethnicity, Customized
Race
Multi-racial/Other
1 Participants3 Participants2 Participants
Race/Ethnicity, Customized
Race
White
16 Participants28 Participants12 Participants
Sex: Female, Male
Female
16 Participants31 Participants15 Participants
Sex: Female, Male
Male
2 Participants4 Participants2 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 170 / 18
other
Total, other adverse events
0 / 170 / 18
serious
Total, serious adverse events
0 / 170 / 18

Outcome results

Primary

Memory for Intentions Test Time Cue Subscale Percentile

Performance on objective prospective memory (time-based)

Time frame: Six weeks

ArmMeasureGroupValue (MEAN)Dispersion
Prospective Memory InterventionMemory for Intentions Test Time Cue Subscale PercentileBaseline35.00 PercentileStandard Deviation 19.75
Prospective Memory InterventionMemory for Intentions Test Time Cue Subscale PercentilePost-treatment57.89 PercentileStandard Deviation 30.53
EducationalMemory for Intentions Test Time Cue Subscale PercentileBaseline51.78 PercentileStandard Deviation 24.09
EducationalMemory for Intentions Test Time Cue Subscale PercentilePost-treatment59.52 PercentileStandard Deviation 29.89
p-value: 0.04ANCOVA
Primary

Memory for Intentions Test Total Score Percentile

Performance on objective prospective memory (overall performance). The MIST Total Score is calculated by summing the raw scores from the six subscales, which is transformed into percentiles using age- and education-stratified normative data. Scores ranged from \<1 9 (coded as 0 for analyses) to \>99 (coded as 100 for analyses), with higher scores indicating better prospective memory performance.

Time frame: Six weeks

ArmMeasureGroupValue (MEAN)Dispersion
Prospective Memory InterventionMemory for Intentions Test Total Score PercentileBaseline32.24 PercentileStandard Deviation 21.78
Prospective Memory InterventionMemory for Intentions Test Total Score PercentilePost-Treatment35.02 PercentileStandard Deviation 22.77
EducationalMemory for Intentions Test Total Score PercentileBaseline38.94 PercentileStandard Deviation 24.29
EducationalMemory for Intentions Test Total Score PercentilePost-Treatment45.40 PercentileStandard Deviation 36.62
p-value: 0.229ANCOVA
Secondary

Perceived Deficits Questionnaire-Prospective Memory Subscale

Subjective prospective memory. The five items in the subscale are summed, with scores ranging between 0 and 20. Higher scores indicate more subjective prospective memory issues.

Time frame: Six weeks

ArmMeasureGroupValue (MEAN)Dispersion
Prospective Memory InterventionPerceived Deficits Questionnaire-Prospective Memory SubscaleBaseline10.18 score on a scaleStandard Deviation 2.7
Prospective Memory InterventionPerceived Deficits Questionnaire-Prospective Memory SubscalePost-Treatment8.79 score on a scaleStandard Deviation 2.6
EducationalPerceived Deficits Questionnaire-Prospective Memory SubscaleBaseline8.44 score on a scaleStandard Deviation 2.55
EducationalPerceived Deficits Questionnaire-Prospective Memory SubscalePost-Treatment8.30 score on a scaleStandard Deviation 2.74
p-value: 0.266ANCOVA

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026